These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35149433)

  • 1. G
    Liu X; Zhu H; Gao H; Tian X; Tan B; Su R
    Biochem Biophys Res Commun; 2022 Apr; 598():20-25. PubMed ID: 35149433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists.
    Karaki S; Becamel C; Murat S; Mannoury la Cour C; Millan MJ; Prézeau L; Bockaert J; Marin P; Vandermoere F
    Mol Cell Proteomics; 2014 May; 13(5):1273-85. PubMed ID: 24637012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of DOM-Induced Head-Twitch Response by mGluR2 Agonist/Inverse Agonist is Associated with 5-HT
    Gao H; Liu X; Xie L; Tan B; Su R
    Neurochem Res; 2024 Mar; 49(3):636-648. PubMed ID: 37989895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The selective 5-HT
    Jensen AA; Halberstadt AL; Märcher-Rørsted E; Odland AU; Chatha M; Speth N; Liebscher G; Hansen M; Bräuner-Osborne H; Palner M; Andreasen JT; Kristensen JL
    Biochem Pharmacol; 2020 Jul; 177():113979. PubMed ID: 32298690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.
    Halberstadt AL; van der Zee JVF; Chatha M; Geyer MA; Powell SB
    Psychopharmacology (Berl); 2019 Feb; 236(2):821-830. PubMed ID: 30448990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Mechanism of the Non-hallucinogenic 5-HT
    Cunningham MJ; Bock HA; Serrano IC; Bechand B; Vidyadhara DJ; Bonniwell EM; Lankri D; Duggan P; Nazarova AL; Cao AB; Calkins MM; Khirsariya P; Hwu C; Katritch V; Chandra SS; McCorvy JD; Sames D
    ACS Chem Neurosci; 2023 Jan; 14(1):119-135. PubMed ID: 36521179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential signaling signatures evoked by DOI versus lisuride stimulation of the 5-HT
    Banerjee AA; Vaidya VA
    Biochem Biophys Res Commun; 2020 Oct; 531(4):609-614. PubMed ID: 32814630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hallucinogen-like effects of 2-([2-(4-cyano-2,5-dimethoxyphenyl) ethylamino]methyl)phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT₂A receptors, in mice.
    Fantegrossi WE; Gray BW; Bailey JM; Smith DA; Hansen M; Kristensen JL
    Psychopharmacology (Berl); 2015 Mar; 232(6):1039-47. PubMed ID: 25224567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral arrest and a characteristic slow waveform are hallmark responses to selective 5-HT
    Contreras A; Khumnark M; Hines RM; Hines DJ
    Sci Rep; 2021 Jan; 11(1):1925. PubMed ID: 33479368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen.
    Canal CE; Olaghere da Silva UB; Gresch PJ; Watt EE; Sanders-Bush E; Airey DC
    Psychopharmacology (Berl); 2010 Apr; 209(2):163-74. PubMed ID: 20165943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex.
    González-Maeso J; Yuen T; Ebersole BJ; Wurmbach E; Lira A; Zhou M; Weisstaub N; Hen R; Gingrich JA; Sealfon SC
    J Neurosci; 2003 Oct; 23(26):8836-43. PubMed ID: 14523084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes.
    Borroto-Escuela DO; Romero-Fernandez W; Narvaez M; Oflijan J; Agnati LF; Fuxe K
    Biochem Biophys Res Commun; 2014 Jan; 443(1):278-84. PubMed ID: 24309097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT
    de la Fuente Revenga M; Jaster AM; McGinn J; Silva G; Saha S; González-Maeso J
    ACS Chem Neurosci; 2022 Aug; 13(16):2436-2448. PubMed ID: 35900876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species.
    Halberstadt AL; Chatha M; Klein AK; Wallach J; Brandt SD
    Neuropharmacology; 2020 May; 167():107933. PubMed ID: 31917152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in senescence-accelerated mice.
    Niimi K; Takahashi E; Itakura C
    Exp Anim; 2010; 59(4):441-7. PubMed ID: 20660990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement.
    Halberstadt AL; Geyer MA
    Psychopharmacology (Berl); 2013 Jun; 227(4):727-39. PubMed ID: 23407781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance and cross-tolerance to head twitch behavior elicited by phenethylamine- and tryptamine-derived hallucinogens in mice.
    Smith DA; Bailey JM; Williams D; Fantegrossi WE
    J Pharmacol Exp Ther; 2014 Dec; 351(3):485-91. PubMed ID: 25271256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selective 5-HT2A receptor agonist 25CN-NBOH does not affect reversal learning in mice.
    Odland AU; Kristensen JL; Andreasen JT
    Behav Pharmacol; 2021 Aug; 32(5):448-452. PubMed ID: 33595957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pimavanserin exhibits serotonin 5-HT
    Muneta-Arrate I; Diez-Alarcia R; Horrillo I; Meana JJ
    Eur Neuropsychopharmacol; 2020 Jul; 36():83-89. PubMed ID: 32517960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gβγ subunit inhibitor decreases DOM-induced head twitch response via the PLCβ/IP3/Ca
    Zhu H; Liu X; Wang X; Li Y; Ma F; Tan B; Zhou P; Fu F; Su R
    Eur J Pharmacol; 2023 Oct; 957():176038. PubMed ID: 37657742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.